Does the anatomical region predict blood loss or neurological deficits in embolized renal cancer spine metastases? A single-center experience with 31 patients

World J Surg Oncol. 2022 Jun 16;20(1):208. doi: 10.1186/s12957-022-02676-1.

Abstract

Background: No comparison of a single hypervascular tumor entity in terms of major complications in different spinal regions has been performed. We aimed to evaluate post-embolic and post-operative outcomes in anatomic regions with renal cell carcinoma (RCC) metastases to the spine.

Methods: We retrospectively evaluated data from patients with confirmed, embolized, and surgically treated RCC spine metastases at a single-spine center between 2010 and 2020. Patients were divided into thoracic (TSM) and lumbar (LSM) spine metastasis groups.

Results: Seventeen patients had TSM and 14 had LSM. In all cases, embolization was performed preoperatively. The ΔHb value did not differ between the two groups pre- and postoperatively (p=0.3934). There was no significant difference in intraoperative blood loss between both groups either within 1 day or 2 days after embolization. Neurological deficits occurred in eight patients after embolization or surgery, with no significant difference between TSM (n=5) and LSM (n=3).

Conclusions: Embolization is the standard procedure for the preoperative treatment of hypervascular spinal metastases, possible up to 48 h before surgery, without the risk of higher intraoperative blood loss. Regardless of intraoperative complications, major complications can occur up to several hours after embolization. We recommend surgery the day after embolization to reliably detect neurologic complications from this procedure.

Keywords: Hyper vascular spinal metastasis; Renal cell carcinoma; Spine surgery of metastasis; Tumor embolization.

MeSH terms

  • Blood Loss, Surgical
  • Carcinoma, Renal Cell* / secondary
  • Carcinoma, Renal Cell* / surgery
  • Embolization, Therapeutic* / adverse effects
  • Embolization, Therapeutic* / methods
  • Humans
  • Kidney Neoplasms* / pathology
  • Kidney Neoplasms* / therapy
  • Preoperative Care / methods
  • Retrospective Studies
  • Spinal Neoplasms* / complications
  • Spinal Neoplasms* / surgery
  • Treatment Outcome